G Proteins and Modulation of Insulin Secretion

Guanine nucleotide–binding proteins (G proteins) are critically important mediators of many signal-transduction systems. Several important sites regulating stimulus-secretion coupling and release of insulin from pancreatic β-cells are modulated by G proteins. Gs mediates increases in intracellular cAMP associated with hormone-induced stimulation of insulin secretion. GI, mediates decreases in intracellular cAMP caused by inhibitors of insulin secretion, e.g., epinephrine, somatostatin, prostaglandin E2, and galanin. G proteins also regulate ion channels, phospholipases, and distal sites in exocytosis. Cholera and pertussis toxins irreversibly ADP ribosylate G proteins and are important tools that can be used both to manipulate G-protein–dependent modulators of insulin secretion and detect and quantify G proteins by electrophoretic techniques. The stage is set to pursue these initial observations in greater depth and ascertain whether G-protein research will provide important new insights into normal and abnormal regulation of insulin secretion.

[1]  L. Birnbaumer,et al.  G proteins in signal transduction. , 1990, Annual review of pharmacology and toxicology.

[2]  L. Olson,et al.  Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit. , 1989, The Journal of biological chemistry.

[3]  E. Seaquist,et al.  Pertussis Toxin–Sensitive G Protein Mediation of PGE2 Inhibition of cAMP Metabolism and Phasic Glucose-Induced Insulin Secretion in HIT Cells , 1989, Diabetes.

[4]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[5]  P. Casey,et al.  G proteins control diverse pathways of transmembrane signaling 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  E. Van Obberghen,et al.  Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. , 1989, The Journal of biological chemistry.

[7]  C. Wollheim,et al.  GTP-dependent inhibition of insulin secretion by epinephrine in permeabilized RINm5F cells. Lack of correlation between insulin secretion and cyclic AMP levels. , 1988, The Journal of biological chemistry.

[8]  S. Metz Epinephrine Impairs Insulin Release by a Mechanism Distal to Calcium Mobilization: Similarity to Lipoxygenase Inhibitors , 1988, Diabetes.

[9]  E. Helmreich,et al.  Structural and functional relationships of guanosine triphosphate binding proteins. , 1988, Current topics in cellular regulation.

[10]  J. Moss,et al.  ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. , 1988, Advances in enzymology and related areas of molecular biology.

[11]  R. Robertson,et al.  Receptor-Mediated Adenylate Cyclase—Coupled Mechanism for PGE2 Inhibition of Insulin Secretion in HIT Cells , 1987, Diabetes.

[12]  A. Couvineau,et al.  Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterization. , 1987, Endocrinology.

[13]  G. Greenberg,et al.  Galanin Inhibits Insulin Secretion and Induces Hyperglycemia in Dogs , 1985, Diabetes.

[14]  C. Wollheim,et al.  Islet cyclic AMP levels are not lowered during alpha 2-adrenergic inhibition of insulin release. , 1984, The Journal of biological chemistry.

[15]  T. Katada,et al.  ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. , 1982, The Journal of biological chemistry.

[16]  T. Katada,et al.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Katada,et al.  Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase. , 1981, The Journal of biological chemistry.

[18]  H. Bourne,et al.  Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Cherksey,et al.  Preponderance of β-Adrenergic Binding Sites in Pancreatic Islet Cells of the Rat , 1981, Diabetes.

[20]  A. Gilman,et al.  Biochemical properties of hormone-sensitive adenylate cyclase. , 1980, Annual review of biochemistry.

[21]  H. Bourne,et al.  Genetic analysis of hormone-sensitive adenylate cyclase. , 1980, Advances in cyclic nucleotide research.

[22]  T. Katada,et al.  Effect of in vivo pretreatment of rats with a new protein purified from Bordetella pertussis on in vitro secretion of insulin: role of calcium. , 1979, Endocrinology.

[23]  G. Weir,et al.  Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. , 1979, The Journal of clinical investigation.

[24]  T. Katada,et al.  Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. , 1979, The Journal of biological chemistry.

[25]  D. Cassel,et al.  Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Katada,et al.  Perfusion of the pancreas isolated from pertussis-sensitized rats: potentiation of insulin secretory responses due to beta-adrenergic stimulation. , 1977, Endocrinology.

[27]  M. Ui,et al.  Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats. , 1975, Endocrinology.

[28]  D. Porte,et al.  Inhibition of in vivo insulin secretion by prostaglandin E1. , 1974, The Journal of clinical investigation.

[29]  I. Burr,et al.  Effects of prostaglandin E1 and of epinephrine on the dynamics of insulin release in vitro. , 1974, Endocrinology.

[30]  D. Porte,et al.  The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. , 1973, The Journal of clinical investigation.

[31]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. , 1971, The Journal of biological chemistry.

[32]  D. Porte Beta Adrenergic Stimulation of Insulin Release in Man , 1967, Diabetes.

[33]  D. Porte A receptor mechanism for the inhibition of insulin release by epinephrine in man. , 1967, The Journal of clinical investigation.

[34]  D. Porte,et al.  The effect of epinephrine on immunoreactive insulin levels in man. , 1966, The Journal of clinical investigation.

[35]  P. J. Randle,et al.  Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. , 1964, The Biochemical journal.